ArticleDiscover oncology2025

DOCK2 modulates immune checkpoint inhibitor responsiveness and prognosis in cutaneous melanoma through multi-omics and single-cell T cell dynamics profiling.

Huicong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.